Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
32.6%
% of IDNA's 51 holdings also in CNCR
23.4%
% of CNCR's 64 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 4.2% | 1.8% | 1.8% |
 |
EXELIXIS INC | 5.2% | 1.8% | 1.8% |
|
JANUX THERAPEUTICS, INC. | 2.4% | 1.7% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 4.0% | 1.7% | 1.7% |
|
ARCELLX, INC. | 3.8% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CNCR
 |
BEIGENE, LTD. | 5.8% |
 |
ROCHE HOLDING LTD | 5.5% |
 |
SANOFI-AVENTIS | 5.5% |
 |
GSK PLC | 5.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 5.2% |
|
ASTRAZENECA PLC | 5.1% |
 |
GENMAB A/S | 4.6% |
|
INCYTE CORP | 4.0% |
|
TWIST BIOSCIENCE CORP. | 3.6% |
|
EXELIXIS INC | 3.5% |
IDNA Underweight Relative to CNCR
|
SUMMIT THERAPEUTICS INC | -2.2% |
|
FATE THERAPEUTICS INC | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -1.8% |
|
2SEVENTY BIO, INC. | -1.8% |
|
ARVINAS, INC. | -1.8% |
|
Y-MABS THERAPEUTICS, INC. | -1.8% |
|
GENMAB A/S SPONSORED ADR | -1.7% |
|
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.7% |
|
NUVATION BIO INC CLASS A | -1.7% |